Tag: Singularity Tracker
-
Twelve Kurzweil longevity predictions from 2005, scored against a 2025 mouse rejuvenation trial, a 2026 first-in-human reprogramming IND, 25 senolytic clinical trials, and one bankruptcy.
-
Seven approved RNAi drugs, one CRISPR medicine for sickle cell, and a stem-cell cure inching toward filing — but every one arrived through mechanisms Kurzweil did not forecast in 2005.
-
Solar got cheap, space-to-Earth microwave beaming flew in 2023, and glucose fuel cells power pacemakers — but the molecular-nanotechnology vehicles Kurzweil picked all missed.
-
Ray Kurzweil’s 2005 answer to his critics rested on reversible computing, algorithmic progress, and the claim that complex software isn’t brittle. Twenty years later, the silicon held up. The software part did not.
-
Frontier and Hala Point already exceed the computing capacity Kurzweil predicted for human-brain emulation by the mid-2020s. Almost every architectural detail he attached to the prediction was wrong.
-
Intel built an owl-scale neuromorphic box, MICrONS mapped a cubic millimeter of mouse cortex, and the Human Brain Project wrapped. Kurzweil’s 2020s whole-brain deadline did not survive the decade.
-
Kurzweil bet that reverse-engineering the brain was the road to AGI. The intelligence arrived on a different road — and it runs on a learning rule he called biologically unrealistic.
-
Kurzweil’s 2005 proof-of-concept examples for AI diagnostics had a 50% mortality rate at the exemplar level — and 100% survival at the thesis level.
-
Kurzweil nailed the BCI side of restoring movement. He was wrong about what would actually do the moving.